FFA
ABBV icon

Founders Financial Alliance’s AbbVie ABBV Stock Holding History

Founders Financial Alliance’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.94M Sell
18,132
-303
-2% -$67.2K 0.71% 33
2025
Q4 		$4.21M Buy
18,435
+90
+0.5% +$20.5K 0.8% 27
2025
Q3 		$4.25M Buy
18,345
+20
+0.1% +$4.07K 0.8% 26
2025
Q2 		$3.4M Buy
18,325
+23
+0.1% +$4.28K 0.77% 26
2025
Q1 		$3.83M Buy
18,302
+272
+2% +$52.9K 0.93% 22
2024
Q4 		$3.2M Sell
18,030
-1,450
-7% -$267K 0.88% 22
2024
Q3 		$3.85M Sell
19,480
-318
-2% -$59.3K 1.07% 18
2024
Q2 		$3.4M Sell
19,798
-39
-0.2% -$6.46K 1.01% 19
2024
Q1 		$3.61M Buy
19,837
+13
+0.1% +$2.24K 1.08% 19
2023
Q4 		$3.07M Buy
19,824
+496
+3% +$72.3K 1.19% 14
2023
Q3 		$2.88M Sell
19,328
-691
-3% -$101K 1.26% 13
2023
Q2 		$2.7M Buy
20,019
+502
+3% +$73.6K 1.06% 17
2023
Q1 		$3.11M Buy
19,517
+153
+0.8% +$23.4K 1.55% 7
2022
Q4 		$3.13M Buy
19,364
+93
+0.5% +$14.3K 1.44% 9
2022
Q3 		$2.59M Buy
19,271
+10,221
+113% +$1.47M 1.32% 8
2022
Q2 		$1.39M Sell
9,050
-8,751
-49% -$1.34M 0.7% 33
2022
Q1 		$2.89M Sell
17,801
-1,158
-6% -$168K 1.28% 11
2021
Q4 		$2.57M Buy
18,959
+2,148
+13% +$254K 1.03% 13
2021
Q3 		$1.81M Buy
16,811
+132
+0.8% +$15.1K 0.85% 23
2021
Q2 		$1.88M Buy
16,679
+256
+2% +$28.8K 0.85% 20
2021
Q1 		$1.84M Buy
16,423
+1,483
+10% +$159K 0.91% 20
2020
Q4 		$1.6M Buy
14,940
+2,837
+23% +$273K 0.91% 24
2020
Q3 		$1.06M Buy
+12,103
New +$1.14M 0.63% 34

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Founders Financial Alliance's ABBV Position: Q1 2026 in Review

Founders Financial Alliance reduced its AbbVie (ABBV) stake by 1.6% in Q1 2026, selling an estimated $67.2K and leaving 18,132 shares worth $3.94M. The position accounts for 0.71% of the portfolio, ranked #33.

Founders Financial Alliance first reported a position in ABBV in Q3 2020 and has held it in 23 quarters since. The position peaked at $4.25M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Founders Financial Alliance held 18,132 shares of AbbVie worth $3.94M as of Q1 2026.
  • Founders Financial Alliance sold 303 AbbVie shares in Q1 2026, an estimated $67.2K.
  • AbbVie made up 0.71% of Founders Financial Alliance's portfolio in Q1 2026, its #33 holding.
  • Founders Financial Alliance first reported a position in AbbVie in Q3 2020 and has held it in 23 quarters since.
  • Founders Financial Alliance's AbbVie position peaked at $4.25M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Founders Financial Alliance's 13F filing for Q1 2026, filed 11 May 2026.